Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02968225 · ClinicalTrials.gov registry record · Phase 2
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
A Phase 2 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT02968225 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 40 participants.
The verdict
NCT02968225, a Phase 2 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators hypothesize that this serious game (designed to provide a learning environment that maximizes opportunities for adolescents with autism to discover the functional utility of eye gaze) will improve sensitivity to eye gaze cues, specifically to identify gazed-at objects, and will also lead to increased social attention to faces in adolescents with autism. The investigators will test this hypothesis in a small-scale exploratory randomized control trial that will include both behavioral and eye tracking outcome measures.
Interventions
- BEHAVIORAL Computer Game
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02968225
The ClinicalTrials.gov registry entry for NCT02968225 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer Game is the first listed.
NCT02968225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02968225 about?
NCT02968225 is a clinical study titled "Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism". The investigators hypothesize that this serious game (designed to provide a learning environment that maximizes opportunities for adolescents with autism to discover the functional utility of eye gaze) will improve sensitivity to eye gaze cues, specifically to identify gazed-at objects, and will als...
What is the current status of trial NCT02968225?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2016-08. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02968225?
The interventions under investigation include: Computer Game (BEHAVIORAL).
Who is sponsoring clinical trial NCT02968225?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.